EMDIN, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 9.071
AS - Asia 4.698
EU - Europa 4.042
SA - Sud America 661
AF - Africa 261
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 18.745
Nazione #
US - Stati Uniti d'America 8.776
SG - Singapore 1.621
CN - Cina 1.263
IT - Italia 842
SE - Svezia 823
HK - Hong Kong 698
BR - Brasile 550
PL - Polonia 539
DE - Germania 480
VN - Vietnam 367
GB - Regno Unito 265
BG - Bulgaria 212
CA - Canada 192
FR - Francia 169
UA - Ucraina 149
FI - Finlandia 145
IN - India 134
RU - Federazione Russa 128
TR - Turchia 127
KR - Corea 106
AT - Austria 92
JP - Giappone 90
CI - Costa d'Avorio 89
BD - Bangladesh 64
SN - Senegal 57
CH - Svizzera 56
MX - Messico 52
IQ - Iraq 41
NL - Olanda 28
ZA - Sudafrica 28
ES - Italia 26
AR - Argentina 25
PK - Pakistan 22
SA - Arabia Saudita 22
ID - Indonesia 21
NG - Nigeria 21
EC - Ecuador 20
JO - Giordania 19
UZ - Uzbekistan 19
BE - Belgio 17
KE - Kenya 17
VE - Venezuela 16
CZ - Repubblica Ceca 15
LT - Lituania 15
MA - Marocco 13
NP - Nepal 12
PE - Perù 11
IE - Irlanda 10
UY - Uruguay 10
CO - Colombia 9
EG - Egitto 9
JM - Giamaica 9
CL - Cile 8
IL - Israele 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
AL - Albania 6
ET - Etiopia 6
HN - Honduras 6
HR - Croazia 6
KG - Kirghizistan 6
PY - Paraguay 6
BB - Barbados 5
BH - Bahrain 5
BO - Bolivia 5
CR - Costa Rica 5
IR - Iran 5
OM - Oman 5
PA - Panama 5
SY - Repubblica araba siriana 5
AU - Australia 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
EU - Europa 4
PH - Filippine 4
TN - Tunisia 4
AO - Angola 3
DZ - Algeria 3
GR - Grecia 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
LY - Libia 3
MY - Malesia 3
RS - Serbia 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BJ - Benin 2
BM - Bermuda 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
DK - Danimarca 2
GA - Gabon 2
KZ - Kazakistan 2
MN - Mongolia 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BZ - Belize 1
EE - Estonia 1
GD - Grenada 1
Totale 18.725
Città #
Ashburn 930
Singapore 875
Woodbridge 724
San Jose 702
Hong Kong 691
Santa Clara 675
Houston 588
Ann Arbor 563
Fairfield 521
Chandler 460
Dallas 383
Shanghai 305
Seattle 234
Beijing 228
Sofia 212
Cambridge 206
New York 203
Jacksonville 187
Wilmington 180
Los Angeles 169
Boardman 168
Serra 150
Milan 137
Ottawa 130
Munich 121
Seoul 105
Hefei 97
London 97
Ho Chi Minh City 96
Lawrence 93
Princeton 93
Abidjan 89
Lauterbourg 82
Tokyo 82
Vienna 81
Hanoi 79
Medford 78
Nanjing 76
Izmir 74
Frankfurt am Main 73
Florence 71
Pisa 58
Buffalo 57
Dakar 57
Dearborn 53
Bern 50
São Paulo 50
Des Moines 45
Turku 44
Redondo Beach 42
Nanchang 34
Jüchen 32
Bremen 31
Council Bluffs 31
Istanbul 30
Dong Ket 28
Warsaw 28
Helsinki 27
Düsseldorf 24
Kent 23
Ogden 23
Lancaster 22
San Diego 22
Chicago 21
Da Nang 21
Lucca 21
Orem 21
Pune 21
Rome 21
Atlanta 20
Boulder 20
Columbus 19
Montreal 19
Amman 18
Changsha 18
Tashkent 18
Brooklyn 17
Brussels 17
Fuzhou 17
Lagos 17
Denver 16
Guangzhou 16
Kunming 16
San Francisco 16
Baghdad 15
Dhaka 15
Hebei 15
Hyderabad 15
Mexico City 15
Redwood City 15
Washington 15
Stockholm 14
Belo Horizonte 13
Brasília 13
Nairobi 13
Paris 13
Tianjin 13
Haiphong 12
Norwalk 12
Rio de Janeiro 12
Totale 12.529
Nome #
Gamma-glutamyltransferase as a cardiovascular risk factor 668
Additive prognostic value of gamma-glutamyltransferase in coronary artery disease 229
Spectral analysis of cardiovascular time series by the S-Transform 213
A multiresolution transform for the analysis of cardiovascular time series 210
Development of an electronic medical record for patient care in cardiology 209
Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque 207
Additive prognostic value of gamma-glutamyltransferase in coronary artery disease 206
Effectiveness of adaptive filtering in cancelling the respiratory component from cardiovascular series 201
Bivariate spectral analysis of nonstationary cardiovascular variability series through cross Wigner distribution 200
High-sensitivity gamma-glutamyltransferase fraction pattern in alcohol addicts and abstainers. 200
New techniques to assess autonomic cardiovascular regulation 191
Time-Dependent analysis of autonomic test: a method based on Wigner-Ville power spectral density estimation 191
An open system for managing long-term ECG recordings 190
Alteration of lactate production during incremental excercise in myotonic dystrophy is not dependent by catecholamine increase 189
Fractions of plasma gamma-glutamyltransferase in healthy individuals: Reference values 186
Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study. 186
Heart rate variability and myocardial infarction: acute and subacute phase 185
Estimation of the power spectral density in nonstationary cardiovascular time series: assessing the role of the time-frequency representations (TFR) 183
Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT 179
Hypnosis effect on RR interval and blood pressure variability 177
Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case. 177
Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: A clinical, neuroradiological and virological response after treatment with risperidone 176
Fractions of Gamma-Glutamyltransferase in healthy individuals, alcohol addicts and patients with hepatic disease 176
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure 175
Altitude distress influence on cardiac function 175
: The potential roles of gamma-glutamyltransferase activity in the progression of atherosclerosis and cardiovascular diseases 171
Personality traits and heart rate variability predict long-term cardiac mortality after myocardial infarction 170
Early assessment of heart rate variability is predictive of in-hospital death and major complications after acute myocardial infarction. , 96:361-368, 2004 169
Beta-lipoprotein- and LDL-associated serum Gamma-glutamiyltransferase in patients with coronary atherosclerosis 169
γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery 169
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 167
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 166
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 164
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 163
Post-mortem CMR in a model of sudden death due to myocardial ischemia: validation with connexin-43 162
Remote biosignal monitoring, display, online analysis and retrieval 161
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 160
Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity 159
ECG Devices interoperability in Hospital environment: clinical experience 159
Serum gamma-glutamyltransferase and intima-media thickness: pointing again to wall/lumen interactions in atherosclerosis. 159
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 159
18-FDG PET for large vessel vasculitis diagnosis and follow-up 159
Gamma-glutamiltransferasi e prognosi cardiovascolare: rivelazione e caratterizzazione di diverse forme di associazione dell’enzima nel plasma 156
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 156
Postmortem cardiac magnetic resonance in sudden cardiac death 156
Method of detecting and separating serum gamma-glutamyltransferase (GGT) isoforms in a sample of biological fluid and the enzyme isoforms thereby obtained. 152
Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability 152
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 152
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 151
Medical record system for cardiology and cardiac surgery 150
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 149
γ-glutamyltransferase and pathogenesis of cardiovascular diseases 148
Serum γ-glutamiltransferase: A new factor in atherosclerotic plaque progression? 147
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 147
Highly Elevated Plasma γ-Glutamyltransferase Elevations: A Trait Caused by γ-Glutamyltransferase 1 Transmembrane Mutations 145
Gamma-glutamiltransferasi: rivelazione e quantificazione di diverse forme di associazione dell’enzima nel plasma 143
Plasma γ-glutamyltransferase fractions: diagnostic and prognostic predictive value 142
Serum gamma-glutamyltransferase as a risk factor of ischemic stroke might be independent of alcohol consumption 142
Characterization of Phenotypic Variability in Becker Muscular Dystrophy for Clinical Practice and Towards Trial Readiness: A Two-Years Follow up Study 141
When the heart is burning: Amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease 141
Serum gamma-glutamyl transpeptidase: a prognostic marker in cardiovascular diseases 139
Use of an electronic medical record in a department of cardiology 137
null 137
Emerging Biochemical Risk Markers of Stroke 137
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 137
Cardiomiopatia dilatativa familiare associata a miopatia 134
Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction 134
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 132
Caso clinico: cardiopatia in una portatrice di distrofia muscolare di Duchenne 132
Forme molecolari della γ-glutammiltransferasi: Caratteristiche e biogenesi 131
La gamma-glutamiltranspeptidasi sierica: un nuovo fattore nella progressione della placca aterosclerotica? 130
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 130
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 129
Heart rate variability modified by altitude exposure 129
Partial lipodystrophy and lmna p.R545h variant 126
Rituximab as a novel treatment for heart failure: Evidence from a case series 123
Unilateral Adrenal Hyperplasia in the Presence of a Reninoma in a Young Pregnant Woman 121
Serum γ-glutamyltransferase: Linking together environmental pollution, redox equilibria and progression of atherosclerosis? 117
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy 116
Platelet activation, gamma-glutamyltransferase and stent restenosis - Comment on the article by Ulus et al 115
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 115
Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease 113
Cardiac magnetic resonance in patients with muscular dystrophies 113
Lipids, glutathione and other key players in Redox cardiology 112
Chronotropic response to vasodilator-stress in patients submitted to myocardial perfusion imaging: impact on the accuracy in detecting coronary stenosis 111
Use of biomarkers to diagnose and manage cardiac amyloidosis 111
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 110
Biomarkers: monoclonal protein and indicators of cardiac damage. 109
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 109
Biventricular Tissue Tracking with Cardiovascular Magnetic Resonance: Reference Values of Left- and Right-Ventricular Strain 109
null 108
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 108
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient 108
[Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC)] 108
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 108
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 107
Molecular autopsy of sudden cardiac death in the genomics era 107
A high performance gel filtration chromatography method for gamma-glutamyltransferase fraction analysis 106
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 103
null 103
Totale 15.499
Categoria #
all - tutte 52.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 0 0 0 0 0 0 97
2021/20221.093 10 54 18 102 208 138 50 33 64 49 93 274
2022/20231.743 236 306 126 133 173 197 28 133 294 1 110 6
2023/20241.663 121 108 127 64 133 222 73 37 21 526 101 130
2024/20254.357 49 155 68 201 461 479 317 186 379 488 450 1.124
2025/20265.130 419 566 464 493 598 428 811 276 293 537 206 39
Totale 18.967